The latest quarterly R&D expense is $91.93 Million with a QoQ Growth of +14.87%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $91.93M.
$91.93M
$91.93 Million
Q2 FY2026 · 2026-06-30
+14.87%
vs. $80.03M prior quarter
18
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $91.93M | +14.87% | +26.87% |
| Q1 FY2026Period end 2026-03-31 | $80.03M | +4.30% | +15.40% |
| Q4 FY2025Period end 2025-12-31 | $76.73M | +5.59% | +8.29% |
| Q3 FY2025Period end 2025-09-30 | $72.67M | +0.29% | +30.30% |
| Q2 FY2025Period end 2025-06-30 | $72.46M | +4.48% | +30.01% |
| Q1 FY2025Period end 2025-03-31 | $69.35M | -2.13% | +23.62% |
| Q4 FY2024Period end 2024-12-31 | $70.86M | +27.06% | +34.62% |
| Q3 FY2024Period end 2024-09-30 | $55.77M | +0.06% | -60.57% |
| Q2 FY2024Period end 2024-06-30 | $55.73M | -0.65% | +68.61% |
| Q1 FY2024Period end 2024-03-31 | $56.10M | +6.58% | +60.13% |
| Q4 FY2023Period end 2023-12-31 | $52.63M | -62.79% | +83.32% |
| Q3 FY2023Period end 2023-09-30 | $141.46M | +327.94% | +370.11% |
| Q2 FY2023Period end 2023-06-30 | $33.05M | -5.64% | +37.45% |
| Q1 FY2023Period end 2023-03-31 | $35.03M | +22.01% | +53.73% |
| Q4 FY2022Period end 2022-12-31 | $28.71M | -4.58% | N/A |
| Q3 FY2022Period end 2022-09-30 | $30.09M | +25.12% | N/A |
| Q2 FY2022Period end 2022-06-30 | $24.05M | +5.53% | N/A |
| Q1 FY2022Period end 2022-03-31 | $22.79M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
